PVLA
Palvella Therapeutics
PVLA
PVLA
46 hedge funds and large institutions have $7.33M invested in Palvella Therapeutics in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
39% less capital invested
Capital invested by funds: $12M → $7.33M (-$4.7M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
46
Holding in Top 10
–
Calls
$14K
Puts
$1K
Top Buyers
| 1 | +$318K | |
| 2 | +$125K | |
| 3 | +$119K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$19.2K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$18.7K |
Top Sellers
| 1 | -$984K | |
| 2 | -$23.3K | |
| 3 | -$19.7K | |
| 4 |
Millennium Management
New York
|
-$10.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6.73K |